SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-21-014600
Filing Date
2021-04-27
Accepted
2021-04-27 17:03:24
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A nc10020690x2_defa14a.htm DEFA14A 17629
2 nc10020690x2_nc01.jpg GRAPHIC 770565
3 nc10020690x2_nc02.jpg GRAPHIC 451934
  Complete submission text file 0001140361-21-014600.txt   1663388
Mailing Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560
Business Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36500 | Film No.: 21859895
SIC: 2834 Pharmaceutical Preparations